FG-3019
Based on 2 publication(s) in Google Scholar
FG-3019 (Pamrevlumab) is a recombinant human antibody that binds to connective tissue growth factor (CTGF). FG-3019 can be used for the research of idiopathic pulmonary fibrosis (IPF).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : ≥99.0%
- CAS. Nr.: 946415-13-0
- Molecular Weight:144.86 kDa
-
Speicherung:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
CTGF
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Anwendung
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized CCN2/CTGF Protein, Human can bind Pamrevlumab . The EC50 for this effect is 6.731 ng/mL.
Product Details
-
CAS. Nr. 946415-13-0
-
Accession P29279
-
Synonyms Pamrevlumab; Anti-Human CTGF Recombinant Antibody
-
Molecular Weight 144.86 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG1 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG1 kappa
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Reinheit
≥99.0%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Versand
Shipping with dry ice.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
Aberrant intermediate alveolar epithelial cells promote pathogenic activation of lung fibroblasts in preclinical fibrosis models. [Abstract]2025 Sep 30;16(1):8710. PMID: 41027873 -
FG-3019 purchased from MedChemExpress. Usage Cited in: Acta Pharm Sin B. 2026 Feb 26.
Wild-type (WT) mice were treated with PBS, and Mdx mice were treated with PBS, FG-3019 (50 mg/kg), TGF-β1 antibody (TGF-β1 ab), FG-3019 + TGF-β1 antibody (CTGF + F + T), and IgG for 6 weeks. Western blot analysis of myofibril and collagen III levels was then performed.
FG-3019 purchased from MedChemExpress. Usage Cited in: Acta Pharm Sin B. 2026 Feb 26.
Masson staining was used to detect the diaphragm of wild-type (WT) mice treated with PBS, and mdx mice treated with PBS, Apc003OA, FG-3019 (50 mg/kg), Apc003OA+BP, and BP.
Reinheit & Dokumentation
Verweise
[1]. Sgalla G, et, al. Pamrevlumab for the treatment of idiopathic pulmonary fibrosis. Expert Opin Investig Drugs. 2020 Aug;29(8):771-777. [Content Brief]
[2]. Neesse A, et, al. CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer. Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12325-30. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)